Marchal A, Cuny J-F, Montagne K, Haroche J, Barbaud A, Schmutz J-L
Service de dermatologie, hôpitaux de Brabois, CHU Nancy, bâtiment des spécialités médicales Philippe-Canton, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France.
Ann Dermatol Venereol. 2011 Nov;138(11):743-7. doi: 10.1016/j.annder.2011.06.002. Epub 2011 Aug 9.
Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis with multiple organ involvement affecting middle-aged adults. A case of ECD associated with Langerhans cell histiocytosis (LCH) is reported herein.
A 75-year-old woman presented maculopapular skin lesions on her trunk, associated with constrictive pericarditis and pleurisy present for 1 year. The skin biopsy militated in favour of LCH since it revealed a histiocytic infiltrate with a positive CD1a marker at immunohistochemistry (IHC). The association with ECD was diagnosed on the basis of pericarditis, periaortitis, pleurisy, pulmonary involvement and retroperitoneal fibrosis. The patient was treated with interferon-α2a with good initial results, but died from septic shock a year and a half later, a few months after discontinuing interferon due to poor tolerability.
The clinical, radiographic and histological arguments in favour of ECD clearly differ from those for LCH. However, as already reported, the two illnesses may be associated, thus underlining the possible existence of a link between these two histiocytic proliferations emanating from the same medullary precursor. Two hypotheses have been advanced in an attempt to explain this association: the first involves a stimulus that might lead to independent proliferation of the two cell lines while the second suggests the existence of a transformation pathway from one form of proliferation to the other.
Screening for associated ECD should be routinely performed in patients presenting LCH with signs evocative of ECD.
厄尔德海姆-切斯特病(ECD)是一种罕见的非朗格汉斯细胞组织细胞增多症,可累及多个器官,好发于中年成年人。本文报告一例与朗格汉斯细胞组织细胞增多症(LCH)相关的ECD病例。
一名75岁女性,躯干出现斑丘疹样皮肤病变,伴有缩窄性心包炎和胸膜炎,病程1年。皮肤活检显示组织细胞浸润,免疫组化(IHC)中CD1a标记呈阳性,提示LCH。基于心包炎、主动脉周炎、胸膜炎、肺部受累及腹膜后纤维化,诊断为ECD合并LCH。患者接受α-干扰素2a治疗,初期效果良好,但因耐受性差,在停药几个月后,于一年半后死于感染性休克。
支持ECD的临床、影像学和组织学依据与LCH明显不同。然而,如既往报道,这两种疾病可能相关,从而强调了这两种源自同一骨髓前体的组织细胞增殖之间可能存在联系。为解释这种关联,提出了两种假说:第一种涉及可能导致两种细胞系独立增殖的刺激因素,第二种则表明存在从一种增殖形式向另一种增殖形式的转化途径。
对于出现提示ECD体征的LCH患者,应常规筛查是否合并ECD。